If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||
![]() HistopathologyVolume 55 Issue 5, Pages 525 - 534 Published Online: 4 Nov 2009 Journal compilation © 2010 Blackwell Publishing Ltd Published on behalf of the British Division of the International Academy of Pathology
Abstract | References | Full Text: HTML, PDF (Size: 1399K) | Related Articles | Citation Tracking Renal epithelioid angiomyolipoma: a study of six cases and a meta-analytic study. Development of criteria for screening the entity with prognostic significance Copyright Journal compilation © 2009 Blackwell Publishing Ltd KEYWORDS angiomyolipoma • carcinoma • epithelioid • kidney • PEComa Faraji H, Nguyen B N & Mai K T (2009) Histopathology55, 525–534 Renal epithelioid angiomyolipoma: a study of six cases and a meta-analytic study. Development of criteria for screening the entity with prognostic significance ABSTRACTAims: Renal epithelioid angiomyolipoma (EAML) is only described in case reports or in multi-institutional small series. The aim was to report cases seen at our institution and to perform a meta-analysis based on a literature review. Methods and results: Six EAML cases seen at our institution were reviewed and a meta-analysis performed using cases retrieved from a literature review. There were a total of 69 cases for review. The male:female ratio was 1:3. In the absence of areas of typical AML, useful features in distinguishing EAML from epithelial renal neoplasms include: extreme degree of cytological atypia, histiocytoid appearance, presence of melanocytic pigments, solid architecture with the absence of frequent areas of alveolar pattern, tubulo-papillary formation and scarring. A fatal outcome, distant or lymph node metastasis, venous invasion and local recurrence were considered as adverse events and occurred in 40% of cases over a period of follow-up of 3–60 months (mean 22.5 ± 18 months). Tumours with an unfavourable outcome showing marked cytological atypia and extensive tumour necrosis were larger (135 ± 43 mm) than those with a favourable outcome (79 ± 50 mm) (P < 0.002), and predominantly occurred in men. Conclusions: Renal neoplasms with certain unusual features should be investigated immunohistochemically to rule out the possibility of EAML. The frequency of adverse outcome is lower in EAML than in renal cell carcinoma. Date of submission 18 November 2008 Accepted for publication 19 March 2009 |